LENZ · Forms 3, 4, 5
Insider trades at LENZ Therapeutics, Inc.
No open-market insider buys or sells at LENZ Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for LENZ Therapeutics, Inc. (LENZ) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for LENZ Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director | Options or other derivatives | Form 4 | ||||
| Jeffrey P. George | Director | Options or other derivatives | Form 4 | ||||
| Kimberlee C Drapkin | Director | Options or other derivatives | Form 4 | ||||
| James W Mccollum | Director | Options or other derivatives | Form 4 | ||||
| Shelley B Thunen | Director | Options or other derivatives | Form 4 | ||||
| Frederic Guerard | Director | Options or other derivatives | Form 4 | ||||
| Zachary Scheiner | Director | Options or other derivatives | Form 4 | ||||
| Jeffrey P. George | Director | Buy | 5,592 | $8.92 | $50K | Form 4 | |
| Evert B. Schimmelpennink | President, CEO and Secretary | Buy | 28,089 | $8.95 | $251K | Form 4 | |
| Daniel R. Chevallard | Chief Financial Officer | Buy | 7,500 | $8.57 | $64K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.